| scholarly article | Q13442814 |
| P50 | author | Brian H Annex | Q105145959 |
| P2093 | author name string | Richard J Price | |
| Ji Song | |||
| Joshua L Heuslein | |||
| Stephanie P McDonnell | |||
| P2860 | cites work | MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. | Q54733079 |
| Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial I | Q56610961 | ||
| Monocyte Chemotactic Protein-1 Increases Collateral and Peripheral Conductance After Femoral Artery Occlusion | Q60495153 | ||
| Safety and efficacy of subcutaneous-only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease | Q81416804 | ||
| Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease | Q84091677 | ||
| The temporal and spatial distribution of macrophage subpopulations during arteriogenesis | Q86079483 | ||
| miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice | Q24595073 | ||
| NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses | Q24670080 | ||
| MicroRNAs and Endothelial (Dys) Function | Q26775547 | ||
| MicroRNAs in flow-dependent vascular remodelling | Q27002530 | ||
| Fiji: an open-source platform for biological-image analysis | Q27860912 | ||
| A MicroRNA93-Interferon Regulatory Factor-9-Immunoresponsive Gene-1-Itaconic Acid Pathway Modulates M2-Like Macrophage Polarization to Revascularize Ischemic Muscle | Q30252768 | ||
| Vascular growth responses to chronic arterial occlusion are unaffected by myeloid specific focal adhesion kinase (FAK) deletion | Q30276705 | ||
| Mechanisms of Amplified Arteriogenesis in Collateral Artery Segments Exposed to Reversed Flow Direction | Q30278752 | ||
| Computational Network Model Prediction of Hemodynamic Alterations Due to Arteriolar Rarefaction and Estimation of Skeletal Muscle Perfusion in Peripheral Arterial Disease. | Q30300196 | ||
| Despite normal arteriogenic and angiogenic responses, hind limb perfusion recovery and necrotic and fibroadipose tissue clearance are impaired in matrix metalloproteinase 9-deficient mice | Q30358598 | ||
| Loss of interleukin-21 receptor activation in hypoxic endothelial cells impairs perfusion recovery after hindlimb ischemia | Q30359086 | ||
| MicroRNA-93 controls perfusion recovery after hindlimb ischemia by modulating expression of multiple genes in the cell cycle pathway | Q30413602 | ||
| Laser speckle flowmetry method for measuring spatial and temporal hemodynamic alterations throughout large microvascular networks | Q30416987 | ||
| Angiogenesis in skeletal muscle precede improvements in peak oxygen uptake in peripheral artery disease patients | Q30422358 | ||
| Relationship between leg muscle capillary density and peak hyperemic blood flow with endurance capacity in peripheral artery disease | Q30426220 | ||
| Spatial and temporal coordination of bone marrow-derived cell activity during arteriogenesis: regulation of the endogenous response and therapeutic implications | Q30430026 | ||
| Bone marrow-derived cell-specific chemokine (C-C motif) receptor-2 expression is required for arteriolar remodeling | Q30434254 | ||
| Capillary arterialization requires the bone-marrow-derived cell (BMC)-specific expression of chemokine (C-C motif) receptor-2, but BMCs do not transdifferentiate into microvascular smooth muscle | Q30434721 | ||
| Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis | Q30438396 | ||
| Therapeutic angiogenesis for critical limb ischaemia | Q30456666 | ||
| Myoglobin overexpression inhibits reperfusion in the ischemic mouse hindlimb through impaired angiogenesis but not arteriogenesis | Q30457043 | ||
| Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. | Q33198267 | ||
| START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease | Q33221332 | ||
| Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells | Q34229735 | ||
| Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). | Q34586454 | ||
| Role of microRNAs in vascular diseases, inflammation, and angiogenesis | Q34786294 | ||
| NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies | Q35022054 | ||
| Inhibition of 14q32 MicroRNAs miR-329, miR-487b, miR-494, and miR-495 increases neovascularization and blood flow recovery after ischemia | Q35217673 | ||
| MicroRNA mediation of endothelial inflammatory response to smooth muscle cells and its inhibition by atheroprotective shear stress | Q35236182 | ||
| Apolipoprotein E enhances microRNA-146a in monocytes and macrophages to suppress nuclear factor-κB-driven inflammation and atherosclerosis | Q35762924 | ||
| Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis. | Q35805173 | ||
| Regulation of monocyte functional heterogeneity by miR-146a and Relb | Q35906690 | ||
| MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy | Q36802746 | ||
| The chemokine system in arteriogenesis and hind limb ischemia | Q36837870 | ||
| Recruitment of the inflammatory subset of monocytes to sites of ischemia induces angiogenesis in a monocyte chemoattractant protein-1-dependent fashion | Q36838523 | ||
| Up-regulation of FGFBP1 signaling contributes to miR-146a-induced angiogenesis in human umbilical vein endothelial cells | Q36845828 | ||
| Suppressed hindlimb perfusion in Rac2-/- and Nox2-/- mice does not result from impaired collateral growth | Q37138949 | ||
| Endothelial Shc regulates arteriogenesis through dual control of arterial specification and inflammation via the notch and nuclear factor-κ-light-chain-enhancer of activated B-cell pathways | Q37570842 | ||
| LPS induces HUVEC angiogenesis in vitro through miR-146a-mediated TGF-β1 inhibition | Q37685263 | ||
| Stimulation of transcription factors NF kappa B and AP1 in endothelial cells subjected to shear stress | Q38307159 | ||
| Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial | Q38400533 | ||
| MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. | Q39144268 | ||
| Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study | Q40594411 | ||
| microRNA-352 regulates collateral vessel growth induced by elevated fluid shear stress in the rat hind limb | Q41159240 | ||
| Paradoxical Suppression of Atherosclerosis in the Absence of microRNA-146a | Q41239832 | ||
| Endothelial nuclear factor-κB-dependent regulation of arteriogenesis and branching | Q41881743 | ||
| Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis. | Q42245007 | ||
| Lipopolysaccharide-induced microRNA-146a targets CARD10 and regulates angiogenesis in human umbilical vein endothelial cells | Q42705521 | ||
| Arteriogenesis proceeds via ICAM-1/Mac-1- mediated mechanisms | Q44826982 | ||
| MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells | Q45002548 | ||
| DNA Methyltransferase 1-Dependent DNA Hypermethylation Constrains Arteriogenesis by Augmenting Shear Stress Set Point. | Q45074404 | ||
| MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression | Q46131735 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 1 | |
| P577 | publication date | 2018-01-22 | |
| P1433 | published in | Frontiers in Bioengineering and Biotechnology | Q21971197 |
| P1476 | title | MicroRNA-146a Regulates Perfusion Recovery in Response to Arterial Occlusion via Arteriogenesis | |
| P478 | volume | 6 |
| Q91522072 | Antibacterial effects of nanopillar surfaces are mediated by cell impedance, penetration and induction of oxidative stress |
| Q93017847 | Applications of Ultrasound to Stimulate Therapeutic Revascularization |
| Q56334462 | Exposure of Endothelium to Biomimetic Flow Waveforms Yields Identification of miR-199a-5p as a Potent Regulator of Arteriogenesis |
| Q91816174 | The Extraordinary Role of Extracellular RNA in Arteriogenesis, the Growth of Collateral Arteries |
Search more.